Transition metal phosphide on black phosphorene heterostructure catalyst for hydrogen evolution

This patent family covers a specific class of heterostructure catalysts for the hydrogen evolution reaction (HER): transition-metal phosphides — specifically chromium phosphide (CrP), tungsten phosphide (WP), and vanadium phosphide (VP) — deposited onto a two-dimensional black-phosphorene support. The claimed heterostructure architecture is designed to exploit a work-function shift of at least 100 mV relative to the bulk phosphide reference material, a shift that arises from electronic coupling at the phosphide-phosphorene interface. This interface effect is the central engineering claim: by pairing a catalytically active phosphide with the atomically thin, high-surface-area phosphorene substrate, the combined structure is expected to achieve improved HER kinetics compared to either component in isolation, particularly bulk-phase phosphide electrodes. The strategic importance of this asset lies in its position at the intersection of two converging trends: the rapid scaling of green-hydrogen production infrastructure globally, which creates urgent demand for earth-abundant, platinum-free HER catalysts; and an accelerating academic literature race around phosphide-on-phosphorene heterostructures, which risks anticipating or crowding out claims based on bulk-phosphide compositions alone. This filing was structured explicitly as a continuation-in-part-ready embodiment that preserves priority against that post-filing literature race — making it a defensive but commercially coherent IP position within the broader phosphide catalyst portfolio. The asset is part of the integrated packaging, storage, and PFAS-treatment systems portfolio and was filed with a clear scope differentiation from the bulk-phosphide claims in the same family. Timing matters for this filing. The academic community has moved rapidly on 2D-material-supported catalysts since roughly 2021, and the phosphorene-support combination for HER is now an area of increasing published interest. The value of this asset to a buyer is therefore not purely its computational validation status — which is incomplete and prophetic — but its role as a priority stake in a specific composition space that would otherwise become crowded. A buyer acquiring or licensing this asset secures early-priority composition and device-use claims covering the heterostructure geometry, which are structurally distinct from any bulk-phosphide grants or pending claims held elsewhere.

The materials architecture here is a heterostructure consisting of a crystalline transition-metal phosphide thin film or nanoparticle deposit on a monolayer or few-layer black phosphorene support. Black phosphorene is an anisotropic 2D allotrope of phosphorus with a puckered orthorhombic lattice and a direct bandgap tunable from roughly 0.3 eV in bulk to approximately 2 eV in the monolayer limit. Its surface is chemically reactive and functionalizeable, making it a plausible anchor substrate for transition-metal phosphide nucleation. The phosphide candidates — CrP, WP, and VP — are all earth-abundant, non-precious-metal compounds with established HER activity in their bulk forms, though their activity lags platinum-based catalysts without optimization. The hypothesis embedded in this claim is that depositing these phosphides on phosphorene creates an interfacial electronic environment that shifts the effective work function of the composite by 100 mV or more versus the bulk phosphide reference, and that this work-function modification translates into improved adsorption free energy for hydrogen intermediates (delta-G_H* closer to zero on the Sabatier optimum). No space group has been assigned to the heterostructure as a whole, because the composite is not a single crystal phase — it is an interface system whose properties emerge from the registry, strain, and charge transfer between the phosphide overlayer and the phosphorene substrate. This is an important distinction from bulk or thin-film single-phase catalysts: the claimed performance advantage is explicitly an interface effect, not a bulk property of either component alone. The relevant computational observables for this architecture include the work function of the composite surface, the hydrogen adsorption energy on interfacial and basal-plane sites, the charge-transfer magnitude between the phosphide and the phosphorene, and the structural stability of the interface under electrochemical conditions. From a computational standpoint, the in-house work-function calculation for the heterostructure returned values that were assessed as non-physical — outside the domain of applicability of the model used, likely because heterostructure interface systems with mixed bonding characters (covalent phosphide plus 2D allotrope) can fall outside the training distribution of models optimized for bulk crystalline phases. This result is acknowledged explicitly and is not cited in support of the claims. No multi-potential consensus stability assessment (using machine-learning interatomic potentials such as MACE, CHGNet, MatterSim, or ORB) has been run for the interface geometry, and no DFT source data is currently attached to this asset. The only simulation framing completed is a conceptual HER adsorption framing describing the expected mechanism and the rationale for the work-function metric, which is correctly characterized as prophetic. Bandgap values for the composite heterostructure are not yet calculated. The claimed work-function shift of at least 100 mV is therefore a design target derived from first-principles reasoning about interface dipole formation and charge redistribution, not a measured or DFT-confirmed value for these specific compositions. The technical plausibility is supported by the broader literature on similar 2D-heterostructure systems (e.g., transition-metal dichalcogenide junctions), but the specific compositions CrP, WP, and VP on black phosphorene have not been independently validated within this program to date. The open validation gates — electrochemical overpotential measurement, Tafel slope analysis, and direct work-function measurement by Kelvin probe or ultraviolet photoelectron spectroscopy — represent the experimental milestones needed to convert this from a prophetic composition claim into a demonstrated performance claim.

The green-hydrogen economy is the primary commercial context for this asset. Global green-hydrogen production capacity is projected to grow substantially through 2030 and beyond, driven by industrial decarbonization mandates, national hydrogen strategies in Europe, Japan, South Korea, the United States, and elsewhere, and declining electrolyzer capital costs. HER catalyst performance directly determines electrolyzer efficiency: even a modest reduction in overpotential — the voltage penalty paid above the thermodynamic minimum — translates to meaningful reductions in levelized cost of hydrogen at scale. The global HER catalyst market, including both precious-metal and earth-abundant variants, is estimated at $1–5 billion in addressable value when including catalyst replacement volumes across alkaline, PEM, and anion-exchange-membrane electrolyzer fleets. This is a rough estimate reflecting early market formation; the actual licensing or royalty-bearing revenue opportunity depends heavily on whether the heterostructure performance can be validated against incumbent benchmarks. The primary buyers of this technology are electrolysis system developers (stack and module manufacturers), catalyst coating suppliers, and integrated green-hydrogen project developers who are motivated to reduce or eliminate dependency on platinum-group metal catalysts. Secondary buyers include chemical companies with captive hydrogen demand — refineries, ammonia producers, methanol plants — that are evaluating green-hydrogen integration. The licensing logic is straightforward: if the heterostructure can be demonstrated to match or approach Pt/C overpotentials at a fraction of the material cost, the composition and device-use claims covering CrP, WP, and VP on phosphorene become licensable to any stack manufacturer seeking to operate that catalyst architecture. Royalty structures in catalyst licensing typically follow either per-kilogram catalyst pricing or per-kilowatt electrolyzer capacity, and the early-priority position provided by this asset would be particularly valuable if the phosphide-on-phosphorene HER space consolidates around one of these three metal compositions.

work-function-tuned phosphide-on-phosphorene HER preserving priority

heterostructure-grade selection-invention scope distinct from Family G bulk claim

The most natural strategic acquirer for this asset is an established electrolyzer manufacturer or green-hydrogen technology company seeking to secure early IP positions in platinum-group-metal-free HER catalyst architectures. Companies such as Nel Hydrogen, ITM Power, Plug Power, and Bloom Energy (among others scaling PEM or alkaline electrolysis) have strong incentives to control composition claims covering non-precious HER catalysts, particularly those that offer a defensible heterostructure differentiation from bulk-phosphide art already in the public domain. Chemical catalyst manufacturers with electrochemistry divisions — Johnson Matthey, BASF Catalysts, Umicore — are also logical licensees if the heterostructure performance validates, since they have the manufacturing infrastructure to scale phosphide-on-2D-material coatings and the customer relationships with electrolyzer OEMs. A second tier of strategic interest comes from energy companies and sovereign wealth funds investing directly in green-hydrogen supply chains, who are beginning to acquire or license upstream IP as a hedge against catalyst supply risk. For this tier, the value of the asset is primarily the priority date and the continuation-in-part optionality — locking in a composition claim before the phosphide-on-phosphorene literature matures into a crowded field. Academic spinouts and startup catalyst companies operating in the 2D-material HER space would find this asset valuable as a defensive holding that prevents larger incumbents from asserting bulk-phosphide blocking positions against a heterostructure product. In all cases, the buyer should plan for the cost of experimental reduction-to-practice as part of the acquisition economics.

The dominant risk is that the claimed 100 mV work-function shift is not achieved for one or more of the three recited compositions when experimentally tested. If the heterostructure effect is smaller than 100 mV, the claims as written would not be infringed by a working device, and the asset's commercial leverage depends on narrowing or rewriting claims around whatever shift is actually demonstrated. A secondary risk is that black phosphorene's well-documented ambient instability — it degrades via oxidation in air and under electrochemical conditions — may limit the practical operating lifetime of any working electrode, regardless of initial HER activity. This is a materials engineering challenge rather than a fundamental barrier, but it requires explicit stability engineering (encapsulation, alloying with arsenic or bismuth, protective coating) before the heterostructure can be evaluated under realistic electrolyzer conditions. The prophetic nature of the claims, combined with the out-of-domain computational result, means neither the performance target nor the structural stability of the interface under operating conditions has been verified. The roadmap to de-risk this asset involves three parallel tracks: first, commission converged DFT slab calculations for the three heterostructures to confirm or bound the work-function shift computationally; second, synthesize at least one of the three heterostructures (CrP/phosphorene is the most tractable starting point) and measure overpotential and work function directly; and third, run accelerated stability testing under electrochemical cycling conditions to establish a phosphorene degradation timeline. If the DFT calculations confirm work-function shifts at or above 100 mV for any of the three compositions, the prophetic claim converts to a demonstrated claim through a continuation-in-part filing incorporating that data, substantially strengthening the asset's value. The continuation-in-part structure was designed precisely for this progression, meaning the legal architecture is already in place to capture experimental validation efficiently.